EUCTR2012-000588-26-FI进行中（未招募）1 期
Pharmacokinetics of Levosimendan in Children with acute heart failure - LevoCorKids
eiden University Medical Center0 个研究点目标入组 36 人开始时间: 2017年9月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •All children < 16 years of age receiving levosimendan as part of their treatment for acute heart failure
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 36
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •no informed consent
- •no sampling line at the start of the study
研究者
相似试验
已完成
不适用
Pharmacokinetics of Levosimendan in Children with Acute Heart FailureNL-OMON37072eids Universitair Medisch Centrum36
进行中（未招募）
不适用
What are the blood levels of Levosimendan in children treated for heart failure?Acute heart failure in childrenEUCTR2012-000588-26-NLeiden University Medical Center
已完成
不适用
Pharmacokinetics of Levosimendan in Pediatric Intensive Care UnitsAcute Heart FailureNCT03681379Nantes University Hospital27
招募中
1 期
Effects of Levosimendan in patients being weaned from venoarterial extracorporal membrane oxygenation. A randomized controlled investigator driven phase II trialCardiogenic ShockCTIS2023-508024-36-00Allgemeines Krankenhaus Der Stadt Wien Universitatskliniken46
Unknown
不适用
Levosimendan Pharmacokinetics in ChildrenAcute Heart FailureNCT01704131Leiden University Medical Center36